Get trade alerts

Arrowhead Pharmaceuticals ($ARWR) Insider Trading & Smart Money Activity

Arrowhead Pharmaceuticals, Inc. · Biotechnology · Latest filing Jun 30, 2026

Arrowhead Pharmaceuticals, Inc. ($ARWR) has 14 13F position changes and 1 analyst rating on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
14
Analyst ratings on file
1

ARWR insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 2
Q2 2026 0 0 0 / 0 9 / 3
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ARWR insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Chardan Capital Reiterates to buy PT $90 +6.7%+7.1% Read
13F Trexquant Investment Added +26.17K sh $22.59M -2.2%+0.6% Read
13F State Street Added +92.30K sh $512.48M -2.2%+0.6% Read
13F Fred Alger Management Added +1.51M sh $272.45M -2.2%+0.6% —
13F D. E. Shaw Added +1.04M sh $88.09M -2.2%+0.6% —
13F D. E. Shaw Added +1.04M sh $96.49M -2.2%+0.6% —
13F Baker Bros. Advisors Reduced -182.86K sh $162.43M -2.2%+0.6% —
13F Renaissance Technologies New +1.04M sh $77.13M -5.2%-3.2% —
13F Renaissance Technologies New +1.04M sh $84.48M -5.2%-3.2% —
13F Northern Trust Added +309.58K sh $132.30M -5.2%-3.2% Read
13F Blackrock Reduced -3.16M sh $1.35B -1.0%-4.3% —
13F Blackrock Reduced -3.16M sh $1.46B -1.0%-4.3% —
13F Rhumbline Advisers Added +52.04K sh $32.97M -7.4%-5.9% Read
13F Vanguard Group Reduced -742.75K sh $1.14B -6.5%-6.9%+26.3% —
13F Vanguard Group Reduced -742.75K sh $1.23B -6.5%-6.9%+26.3% Read

1W / 1M / 6M = how ARWR moved from the trade or filing date.

Institutions moving ARWR (13F)

Analyst ratings on ARWR

DateFirmActionRatingPrice target1W1M6MStory
Chardan Capital Reiterates buy $90 +6.7%+7.1% Read

Frequently asked questions

Which institutions changed their ARWR positions?

Recent 13F filers moving the stock include D. E. Shaw, Renaissance Technologies, Blackrock, Vanguard Group and Trexquant Investment.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text